| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Cai,Guo-Quan | Chairman | 14.14% | SyneuRx International Corp. |
| Wu,Cheng-Wen | Director | 14.14% | SyneuRx International Corp. |
| Zhuang,Qiao-Ru | Director | 0.08% | |
| Vacancy | Director | ||
| Vacancy | Director | ||
| Zhang,Mao-Zhong | Director | 0.00% | |
| Zhang,Yang-Zhan | Director | 0.00% | |
| Zhang,Zhen-Wu | Independent Director | 0.00% | |
| Lu,En-Guang | Independent Director | 0.02% | |
| Xu,Zhao-Qing | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 3,178 | 1,322 | - |
| Operating cost | 739 | 270 | - |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 2,439 | 1,052 | - |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 2,439 | 1,052 | - |
| Operating expenses | 29,118 | 140,257 | 309,974 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -26,679 | -139,205 | -309,974 |
| Non-operating income and expenses | -612 | 2,743 | -38,622 |
| Net profit (loss) before tax | -27,291 | -136,462 | -348,596 |
| Income tax expense (benefits) | -180 | 60 | 5,883 |
| Net profit (loss) of ongoing business for the current period | -27,111 | -136,522 | -354,479 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -27,111 | -136,522 | -354,479 |
| Other comprehensive profit (loss), net | 168 | -450 | 1,427 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -26,943 | -136,972 | -353,052 |
| Net profit (loss) attributable to owners of parent company | -27,111 | -132,551 | -353,100 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 0 | -3,971 | -1,379 |
| Comprehensive profit (loss) attributable to owners of parent company | -26,943 | -133,058 | -352,284 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 0 | -3,914 | -768 |
| Basic earnings per share (yuan) | 0 | -1 | -2 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -26,880 | -110,182 | -292,394 |
| Net cash inflows (outflows) from investing activities | 801 | -340 | 125,415 |
| Net cash inflow (outflow) from financing activities | -2,611 | 133,812 | 12,977 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 741 | 390 | 4,804 |
| Increase (decrease) in cash and cash equivalents in the current period | -27,949 | 23,680 | -149,198 |
| Beginning balance of cash and cash equivalents | 100,835 | 77,155 | 226,353 |
| Ending balance of cash and cash equivalents | 72,886 | 100,835 | 77,155 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 108,664 | 136,418 | 132,802 |
| Non-current asset | 13,160 | 16,120 | 35,048 |
| Total asset | 121,824 | 152,538 | 167,850 |
| Current liability | 36,970 | 38,088 | 43,760 |
| Non-current liability | 5,677 | 8,330 | 20,712 |
| Total liability | 42,647 | 46,418 | 64,472 |
| share capital | 1,352,701 | 1,352,701 | 1,210,891 |
| Equity - secruity token | - | - | - |
| capital reserve | 0 | 0 | 18,862 |
| retained earning | -1,273,344 | -1,246,233 | -1,132,544 |
| Other equity | -180 | -348 | 159 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 79,177 | 106,120 | 97,368 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 0 | 0 | 6,010 |
| Total Equity | 79,177 | 106,120 | 103,378 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 0 | 0 | 0 |
